A comprehensive US analysis showed that progress in multiple myeloma survival has not been shared equally, with significant disparities persisting despite improved therapies.

As July concludes, the landscape of hematologic oncology continues to evolve, with notable progress in multiple myeloma, ...

In addition, high-dose chemotherapy followed by autologous stem cell transplant, or ASCT, continues to be the standard of care for multiple myeloma. Studies show that ASCT: ...

Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that starts in your plasma cells. Your plasma cells are a type of white blood cell inside your bone marrow ...

Multiple myeloma (MM) is a form of blood cancer that begins in bone marrow cells called plasma cells. Abnormal plasma cells begin to grow very quickly, preventing bone marrow from making healthy ...